# Lidocaine-Ketamine for Management of Chronic Pain

> **NCT03249025** · NA · UNKNOWN · sponsor: **Hamilton Health Sciences Corporation** · enrollment: 72 (estimated)

## Conditions studied

- Chronic Pain Syndrome

## Interventions

- **DRUG:** Lidocaine
- **DRUG:** Ketamine

## Key facts

- **NCT ID:** NCT03249025
- **Lead sponsor:** Hamilton Health Sciences Corporation
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-09-01
- **Primary completion:** 2018-09-01
- **Final completion:** 2018-09-01
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2017-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03249025

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03249025, "Lidocaine-Ketamine for Management of Chronic Pain". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03249025. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*